Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LMLLF | US
0.00
17.05%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
12/09/2024
0.02
0.02
0.02
0.02
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research development and commercialization of controlled-substances and natural medicines such as psychedelics cannabis and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart an entity building to vertically integrated elevate the use of functional mushrooms and psilocybin mushrooms. In addition the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N N-dimethyltryptamine's (DMT) potential role in normal diseased and altered states of consciousness as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of cepharanthine; and clinical trial agreement with Johns Hopkins University to conduct a clinical study comparing acute and enduring psychological and neural effects of DMT and an undisclosed potently active comparator molecule. Further the company also holds interest in Sairiyo Therapeutics Inc. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug Inc. is based in Toronto Canada.
View LessLow Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
213.7%1 month
230.2%3 months
225.1%6 months
211.6%-
-
0.66
-0.99
1.59
2.73
11.65
-
-1.29M
1.54M
1.54M
-
-
-
-38.00
-377.99
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.01
Range1M
0.03
Range3M
0.03
Rel. volume
0.01
Price X volume
4.83
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
PRFX | PRFX | Drug Manufacturers-Specialty & Generic | 0.83 | 1.12M | -12.63% | n/a | -2.89% |
Alvotech Warrant | ALVOW | Drug Manufacturers-Specialty & Generic | 2.55 | 0 | 2.00% | n/a | -196.14% |
Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.1099 | 0 | n/a | 2.46% | |
Procaps Group S.A. Warrants | PROCW | Drug Manufacturers-Specialty & Generic | 0.0201 | 0 | -32.09% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.5 | 860.26K | -5.66% | n/a | 0.00% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.25 | 0 | -0.28% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 2.73 | - | Cheaper |
Ent. to Revenue | 11.65 | - | Cheaper |
PE Ratio | - | 29.14 | - |
Price to Book | 0.66 | 12.81 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 225.13 | - | Riskier |
Debt to Equity | -0.99 | -0.93 | Cheaper |
Debt to Assets | 1.59 | 0.45 | Expensive |
Market Cap | 1.54M | - | Emerging |